Literature DB >> 1427881

Mapping of the X-linked form of hyper-IgM syndrome (HIGM1) to Xq26 by close linkage to HPRT.

M Padayachee1, C Feighery, A Finn, C McKeown, R J Levinsky, C Kinnon, S Malcolm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1427881     DOI： 10.1016/s0888-7543(05)80270-8

Source DB:  PubMed          Journal:  Genomics        ISSN： 0888-7543            Impact factor:   5.736


× No keyword cloud information.
  13 in total

Review 1.  CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes.

Authors:  A Bhushan; L R Covey
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 2.  The biology of the human ligand for CD40.

Authors:  M K Spriggs; W C Fanslow; R J Armitage; J Belmont
Journal:  J Clin Immunol       Date:  1993-11       Impact factor: 8.317

Review 3.  The hyper-IgM (HIM) syndrome.

Authors:  N Ramesh; M Seki; L D Notarangelo; R S Geha
Journal:  Springer Semin Immunopathol       Date:  1998

4.  Male neonatal death and progressive weakness and immune deficiency in females: an unknown X linked condition.

Authors:  G Woods; G Black; G Norbury
Journal:  J Med Genet       Date:  1995-03       Impact factor: 6.318

5.  Molecular genetic haplotype segregation studies in three families with X-linked lymphoproliferative disease.

Authors:  V Schuster; S Seidenspinner; T Grimm; W Kress; S Zielen; M Bock; H W Kreth
Journal:  Eur J Pediatr       Date:  1994-06       Impact factor: 3.183

6.  Mapping of the X linked form of hyper IgM syndrome (HIGM1)

Authors:  M Padayachee; R J Levinsky; C Kinnon; A Finn; C McKeown; C Feighery; L D Notarangelo; R W Hendriks; A P Read; S Malcolm
Journal:  J Med Genet       Date:  1993-03       Impact factor: 6.318

Review 7.  Recent advances in transplantation for primary immune deficiency diseases: a comprehensive review.

Authors:  M Teresa de la Morena; Robert P Nelson
Journal:  Clin Rev Allergy Immunol       Date:  2014-04       Impact factor: 8.667

8.  Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation.

Authors:  M Teresa de la Morena; David Leonard; Troy R Torgerson; Otavio Cabral-Marques; Mary Slatter; Asghar Aghamohammadi; Sharat Chandra; Luis Murguia-Favela; Francisco A Bonilla; Maria Kanariou; Rongras Damrongwatanasuk; Caroline Y Kuo; Christopher C Dvorak; Isabelle Meyts; Karin Chen; Lisa Kobrynski; Neena Kapoor; Darko Richter; Daniela DiGiovanni; Fatima Dhalla; Evangelia Farmaki; Carsten Speckmann; Teresa Español; Anna Shcherbina; Imelda Celine Hanson; Jiri Litzman; John M Routes; Melanie Wong; Ramsay Fuleihan; Suranjith L Seneviratne; Trudy N Small; Ales Janda; Liliana Bezrodnik; Reinhard Seger; Andrea Gomez Raccio; J David M Edgar; Janet Chou; Jordan K Abbott; Joris van Montfrans; Luis Ignacio González-Granado; Nancy Bunin; Necil Kutukculer; Paul Gray; Gisela Seminario; Srdjan Pasic; Victor Aquino; Christian Wysocki; Hassan Abolhassani; Morna Dorsey; Charlotte Cunningham-Rundles; Alan P Knutsen; John Sleasman; Beatriz Tavares Costa Carvalho; Antonio Condino-Neto; Eyal Grunebaum; Helen Chapel; Hans D Ochs; Alexandra Filipovich; Mort Cowan; Andrew Gennery; Andrew Cant; Luigi D Notarangelo; Chaim M Roifman
Journal:  J Allergy Clin Immunol       Date:  2016-09-30       Impact factor: 10.793

Review 9.  Molecular and genetic basis of X-linked immunodeficiency disorders.

Authors:  J M Puck
Journal:  J Clin Immunol       Date:  1994-03       Impact factor: 8.317

10.  CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency.

Authors:  M Farrington; L S Grosmaire; S Nonoyama; S H Fischer; D Hollenbaugh; J A Ledbetter; R J Noelle; A Aruffo; H D Ochs
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.